Endovascular Aneurysm Repair to Generate Over 50% of Revenues in Vascular Grafts Market
The latest research on the vascular grafts market conducted by Fact.MR uncovers critical trends and opportunities across key segments including, treatment, raw material, end user, and region during the assessment period. The report emphasizes on providing exclusive insights into the market to assist key players in making well-knitted strategies to gain a competitive edge.
NEW YORK, Nov. 2, 2022 /PRNewswire/ -- A Market Research and Competitive Intelligence Provider: The global vascular grafts market is estimated to reach US$ 3.5 billion in 2022 and expand at 6.5% CAGR between 2022 and 2026. Further, sales in the market are expected to surpass a valuation of US$ 4.5 billion by the end of 2026.
Rising prevalence of chronic renal diseases, aortic aneurysms, and cardiovascular illnesses across the world is a key factor providing impetus to the growth of vascular grafts market.
Similarly, growing popularity of next-generation vascular grafts and increasing preference for less invasive procedures are expected to boost the global market during the forecast period.
Furthermore, increasing healthcare expenditures, availability of favorable reimbursement policies, advances in surgical methods utilizing coronary artery stent-grafts, and rising focus on early diagnosis of diseases are expected to boost sales of vascular grafts.
Based on treatment, the endovascular aneurysm repair treatment is expected to grow at 6% CAGR over the projection period. Growing need for less invasive procedures and rising popularity of stent grafts to treat diseases like atherosclerosis are driving the demand for endovascular aneurysm repair surgery procedures.
Download A Free Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=7620
Demand for vascular grafts remains particularly high across hospitals owing to the increasing number of minimally invasive surgical procedures performed in hospitals due to presence of advanced technologies and highly qualified staff.
Regionally, North America is expected to remain at the epicenter of vascular grafts during the projection period. Growth in the North America vascular grafts market is driven by increasing prevalence of chronic diseases, presence of attractive reimbursement policies, and increased investments in research and development.
Key Takeaways:
- By treatment, endovascular aneurysm repair (EVAR) segment accounts for more than 50% share of the global market.
- Based on end user, hospitals segment holds the largest share of the global vascular grafts market.
- North America is likely to retain its dominance in the global vascular grafts market during the forecast period.
- With growing prevalence of aortic aneurysms and atherosclerosis, demand for vascular grafts is expected to rise at a robust pace across the U.S. during the projection period.
- The overall vascular grafts market in China is expected to expand at a CAGR of 8% during the forecast period.
Growth Drivers:
- Rising prevalence of chronic renal disorders and cardiovascular diseases is expected to drive the global vascular grafts market swiftly during the forecast period.
- Increasing number of surgical procedures performed worldwide along with growing popularity of less invasive procedures is likely to boost the market.
- Development of surgical treatments utilizing coronary artery stent-grafts is expected to drive demand for vascular grafts.
- Growing demand for next-generation tissue-engineered vascular grafts for treatment of various chronic diseases will aid in the expansion of the global market.
Restraints:
- A shortage of highly skilled professionals for performing vascular bypass surgery is hindering the growth of the market.
- High cost of vascular grafts and absence of proper reimbursement policies across emerging economies are also restraining market expansion.
Get Customize Report as per Your Requirements!
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7620
Competitive Landscape:
Key competitors in vascular grafts market are implementing a variety of tactics, including partnerships, mergers, acquisitions, and new product development, among others, to stay one step ahead of the competition and increase their market share and income.
For instance,
- In November 2019, Terumo Corporation acquired Aortic Corporation to boost the company's vascular grafts business segment's expansion and contribute to individualized aortic treatment.
- In January 2019, Somahlution, a biotechnology corporation, announced the findings of a clinical trial on DURAGRAFT, which has been shown to have a decreased clinical risk after coronary bypass grafting (CABG).
- Medtronic launched the Endurant II Stent Graft System to treat abdominal aortic aneurysms. This device provides controlled deployment and precise positioning for flexible and kink-resistant graft distribution.
- In September 2021, Terumo Aortic announced PANTHER, a global surgical graft research of knitted and woven surgical grafts.
Key Companies Profiled by Fact.MR
- Endologix Inc.
- OrbusNeich
- Cook Medical
- Cryolife
- Getinge Group
- LeMaitre Vascular Inc
- Medtronic PLC
- Terumo Medical Corporation
- W.L. Gore & Associates Inc.
- Vascular Graft Solution Ltd.
More Valuable Insights on Vascular Grafts Market
In the latest study, Fact.MR offers a detailed study on global vascular grafts market for the forecast period of 2022 to 2026. This study also highlights key drivers promoting the sales of vascular grafts through detailed segmentation as follows:
By Treatment:
- Endovascular Aneurysm Repair (EVAR)
- Peripheral Vascular Repair
- Hemodialysis Access
By Raw Material:
- Polyester
- ePTFE
- Polyurethane
- Biosynthetic
By End User:
- Hospitals
- Ambulatory Surgical Centers
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Explore Safe & Secure Payment Options for Quick Buy!
https://www.factmr.com/checkout/7620
Explore Fact.MR's Coverage on the Healthcare Domain
Vascular Dressings Market: The global dressings market is anticipated to witness a steady growth rate during the forecast period, owing to the rising incidence of road accidents and hospital acquired infections at the needle site and growing health awareness among people.
Vascular Patches Market: As per Fact.MR, the global vascular patches market is expected to grow at a significant pace during the projection period owing rising prevalence of cardiac diseases, increasing adoption of vascular patches for treating cardiac complications, and growing popularity of biocompatible vascular patches.
Vascular Closure Devices Market: As per Fact.MR, the global vascular closure devices market size is projected to grow from US$ 1.1 billion in 2022 to US$ 1.1 billion in 2026, with overall sales accelerating at 6.6% CAGR throughout the forecast period. Rising incidence cardiovascular disorders will drive demand for vascular closure devices during the projection period.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
E: sales@factmr.com
Follow Us: LinkedIn | Twitter | YouTube
Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

Share this article